Long term follow-up results of phase II clinical trial evaluating ruxolitinib (RUX) and azacitidine (AZA) combination therapy in patients (pts) with myelofibrosis (MF)
Arora, Sankalp, Senapati, Jayastu, Masarova, Lucia, Pemmaraju, Naveen, Bose, Prithviraj, Bravo, Guillermo Montalban, Saenz, Dyana T, Halim, Habiba, Zhou, Lingsha, Maiti, Abhishek, Borthakur, Gautam, Kadia, Tapan M., Jabbour, Elias, Garcia-Manero, Guillermo, Kantarjian, Hagop M., Daver, Naval Guastad
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article